Angela Loi

1.8k total citations
21 papers, 487 citations indexed

About

Angela Loi is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Angela Loi has authored 21 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Hematology. Recurrent topics in Angela Loi's work include Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (6 papers) and Trace Elements in Health (3 papers). Angela Loi is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (6 papers) and Trace Elements in Health (3 papers). Angela Loi collaborates with scholars based in Italy, United States and Türkiye. Angela Loi's co-authors include Mario Pirastu, Antonio Cao, Manila Deiana, A Figus, Mario Lovicu, Andrea Angius, Georgios Loudianos, Gabriella Sole, Nazario Olla and Laura Crisponi and has published in prestigious journals such as Blood, Neurology and Developmental Biology.

In The Last Decade

Angela Loi

21 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Loi Italy 14 183 166 152 136 130 21 487
Eric Lo United States 7 291 1.6× 181 1.1× 205 1.3× 112 0.8× 46 0.4× 9 510
Olivier LaRochelle Canada 10 136 0.7× 33 0.2× 154 1.0× 138 1.0× 114 0.9× 12 440
Pauline L. Lee United States 15 719 3.9× 507 3.1× 559 3.7× 168 1.2× 88 0.7× 29 959
Kairen Kukalizch United Kingdom 7 90 0.5× 48 0.3× 111 0.7× 83 0.6× 35 0.3× 9 508
Nicole Wilkinson Canada 8 393 2.1× 254 1.5× 204 1.3× 164 1.2× 19 0.1× 9 615
Marie‐Laure Island France 12 203 1.1× 148 0.9× 137 0.9× 130 1.0× 21 0.2× 22 462
T. Vulliamy United Kingdom 13 115 0.6× 73 0.4× 6 0.0× 398 2.9× 12 0.1× 17 765
Elisa Pignatti Italy 8 1.0k 5.7× 898 5.4× 882 5.8× 91 0.7× 42 0.3× 9 1.2k
Yiqun Huang China 15 47 0.3× 29 0.2× 29 0.2× 315 2.3× 10 0.1× 42 426
Cherylene A. Plewa United States 6 278 1.5× 219 1.3× 109 0.7× 121 0.9× 4 0.0× 8 444

Countries citing papers authored by Angela Loi

Since Specialization
Citations

This map shows the geographic impact of Angela Loi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Loi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Loi more than expected).

Fields of papers citing papers by Angela Loi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Loi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Loi. The network helps show where Angela Loi may publish in the future.

Co-authorship network of co-authors of Angela Loi

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Loi. A scholar is included among the top collaborators of Angela Loi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Loi. Angela Loi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zandberg, Dan P., Robert L. Ferris, Douglas Laux, et al.. (2020). 71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results. Annals of Oncology. 31. S1446–S1447. 23 indexed citations
2.
Buers, Insa, Ivana Persico, Yvonne Nitschke, et al.. (2019). Crisponi/cold‐induced sweating syndrome: Differential diagnosis, pathogenesis and treatment concepts. Clinical Genetics. 97(1). 209–221. 11 indexed citations
3.
Marongiu, Mara, Manila Deiana, Andrea Sbardellati, et al.. (2016). Novel action of FOXL2 as mediator of Col1a2 gene autoregulation. Developmental Biology. 416(1). 200–211. 6 indexed citations
4.
Marongiu, Mara, Emanuele Pelosi, Mario Lovicu, et al.. (2015). FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice. BMC Developmental Biology. 15(1). 27–27. 23 indexed citations
5.
Palomba, Grazia, Angela Loi, Giovanna Piras, et al.. (2009). A role of BRCA1 and BRCA2germline mutations in breast cancer susceptibility within Sardinian population. BMC Cancer. 9(1). 245–245. 17 indexed citations
6.
Ciafaloni, Emma, et al.. (2006). Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology. 67(10). 1887–1889. 35 indexed citations
7.
Crisponi, Laura, Manuela Uda, Manila Deiana, et al.. (2004). FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Genomics. 83(5). 757–764. 42 indexed citations
8.
Fossarello, Maurizio, Ignazio Alberto Zucca, Mario Pirastu, et al.. (1997). Genetic mapping of autosomal dominant primary open-angle glaucoma (POAG) in Sardinia. International Ophthalmology. 20(1-3). 1–5. 4 indexed citations
9.
Loudianos, Georgios, Valeria Dessì, Andrea Angius, et al.. (1996). Wilson disease mutations associated with uncommon haplotypes in mediterranean patients. Human Genetics. 98(6). 640–642. 40 indexed citations
10.
Figus, A, Andrea Angius, Georgios Loudianos, et al.. (1995). Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations.. PubMed. 57(6). 1318–24. 111 indexed citations
11.
Murru, S, Lucia Casarino, Paolo Moi, et al.. (1994). A DNA Fragment from Xq21 Replaces a Deleted Region Containing the Entire FVIII Gene in a Severe Hemophilia A Patient. Genomics. 23(2). 352–361. 2 indexed citations
12.
Loudianos, Georgios, A Figus, Angela Loi, et al.. (1994). Improvement of prenatal diagnosis of wilson disease using microsatellite markers. Prenatal Diagnosis. 14(10). 999–1002. 13 indexed citations
13.
Romão, Luı́sa, F E Cash, Ingrid M. Weiss, et al.. (1992). Human ?-globin gene expression is silenced by terminal truncation of chromosome 16p beginning immediately 3? of the ?-globin gene. Human Genetics. 89(3). 323–8. 16 indexed citations
14.
Rosatelli, Maria Cristina, et al.. (1991). Molecular Basis of Beta-Thalassemia intermedia in a Southern Italian Region (Puglia). Acta Haematologica. 86(4). 174–178. 2 indexed citations
15.
Ottolenghi, Sergio, Clara Camaschella, Paola Comi, et al.. (1988). A frequent A?-persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with ?-thalassemia. Human Genetics. 79(1). 13–17. 18 indexed citations
16.
Loi, Angela, et al.. (1988). ?-thalassemia mutations in the Portuguese population. Human Genetics. 78(1). 13–15. 38 indexed citations
17.
Pirastu, Mario, Giuseppe Saglio, Clara Camaschella, et al.. (1988). Delineation of specific beta-thalassemia mutations in high-risk areas of Italy: a prerequisite for prenatal diagnosis. Blood. 71(4). 983–988. 28 indexed citations
18.
Pirastu, Mario, Giuseppe Saglio, Clara Camaschella, et al.. (1988). Delineation of specific beta-thalassemia mutations in high-risk areas of Italy: a prerequisite for prenatal diagnosis. Blood. 71(4). 983–988. 2 indexed citations
19.
Camaschella, Clara, Giuseppe Saglio, Anna Serra, et al.. (1987). Molecular characterization of thalassemia intermedia in Italy.. PubMed. 23(5A). 111–6. 3 indexed citations
20.
Akar, Nejat, et al.. (1987). Beta thalassaemia mutations in the Turkish population.. Journal of Medical Genetics. 24(6). 378–379. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026